PROPOSAL 2
Approval of the Third Amendment to the Company's Second Amended and Restated 2009 Equity Participation Plan
Required Vote
The affirmative vote of a majority of shares cast and present in person or represented by proxy at the meeting is required to approve the third amendment to the Company's Second Amended and Restated 2009 Equity Participation Plan.
|
Recommendation THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE THIRD AMENDMENT TO THE COMPANY'S SECOND AMENDED AND RESTATED 2009 EQUITY PARTICIPATION PLAN. |
Background
On April 24, 2025, subject to approval of the Company’s stockholders, the Board of Directors of the Company approved and adopted a third amendment (the “Amendment”) to the Company’s Second Amended and Restated 2009 Equity Participation Plan, as amended by that certain first amendment to the Second Amended and Restated Plan, dated as of April 25, 2019 and effective as of June 13, 2019, and as further amended by that certain second amendment to the Second Amended and Restated Plan, dated as of April 26, 2022 and effective as of June 9, 2022 (as amended, the “Second Amended and Restated Plan”), which increases the aggregate number of shares of common stock of the Company that may be issued pursuant to the Second Amended and Restated Plan by an additional 3,400,000 shares, to a total of 24,645,000 shares.
The Amendment to the Second Amended and Restated Plan will become effective on the date on which it is approved by the Company’s stockholders. Unless and until the Company’s stockholders approve the Amendment, we will continue to grant awards under the terms of the Second Amended and Restated Plan using the shares available for issuance, if any, thereunder. If the Amendment is not approved by the Company’s stockholders, the Second Amended and Restated Plan will continue in effect, and we may continue to grant awards under the Second Amended and Restated Plan, subject to its terms, conditions and limitations, using the shares available for issuance thereunder (without giving effect to the Amendment).
The material features of the Second Amended and Restated Plan, as amended by the Amendment, are described below. The description of the Amendment in this proposal is qualified in its entirety by reference to full text of the Amendment, a copy of which is attached as Appendix B to this proxy statement. A conformed copy of the Second Amended and Restated Plan, as amended by the Amendment, is attached as Appendix C to this proxy statement.
Shares Available for Issuance
In 2009, the Board of Directors adopted, and the stockholders of the Company approved, the Kennedy-Wilson Holdings, Inc. 2009 Equity Participation Plan (the “Original Plan”). In 2012, the Board of Directors adopted, and the stockholders of the Company approved, the First Amended and Restated Plan, which was subsequently amended in 2014 and which, as amended, made various changes to the Original Plan, including increasing the number of shares available for issuance from 5,645,000 to 11,645,000 shares in 2014. In 2017, the Board of Directors adopted, and the stockholders of the Company approved, the Second Amended and Restated Plan which made various changes to the Original Plan, as amended, including increasing the number of shares available for issuance from 11,645,000 to 14,945,000. In 2019, the Board of Directors adopted, and the stockholders of the Company approved, the first amendment to the Second Amended and Restated Plan adopted by the Board of Directors on April 25, 2019 to increase the number of shares of our common stock available for issuance thereunder by 3,300,000 shares, to 18,245,000 shares. In 2022, the Board of Directors adopted, and the stockholders of the Company approved, the second amendment to the Second Amended and Restated Plan adopted by the Board of Directors on April 26, 2022 to (among other things) increase the aggregate number of shares of common stock of the Company that may be issued pursuant to the Second Amended and Restated Plan by an additional 3,000,000 shares, to a total of 21,245,000 shares.
As of April 15, 2025, there were 138,293,288 of our common shares outstanding (171,162,048 on a fully diluted basis), an aggregate of 9,293,292 common shares were subject to outstanding awards under the Second Amended and Restated Plan (assuming vesting at “max” levels for all awards), and no shares remained available for issuance under the Second Amended and Restated Plan. The Board of Directors recommends that the Company’s stockholders approve the Amendment to the Second Amended and Restated Plan because it believes the Company’s continued ability to grant equity based long-term incentives to our employees is important to enhancing stockholder value. Absent approval of the Amendment, the Company will have no shares, available for grant under the Second Amended and Restated Plan in the future, which the Company